Table 2.
Factors associated with MTX adherence using linear regression analysis (n = 165)
| Coef | 95% CI | p value | |
|---|---|---|---|
| Age | 0.02 | 0.00–0.03 | 0.03 |
| Female | − 0.09 | − 0.58 to 0.40 | 0.73 |
| Disease duration | 0.00 | − 0.00 to 0.00 | 0.41 |
| RA activity (DAS28-ESR) | 0.16 | − 0.03 to 0.35 | 0.09 |
| Depression state (CES-D) | − 0.26 | − 0.69 to 0.18 | 0.25 |
| Belief about medicine (BMQ necessity-concern differential) | 0.01 | − 0.07 to 0.09 | 0.86 |
| Social desirability (SDS) | 0.14 | 0.05–0.23 | 0.00 |
| Educational level (more than or equal to college level or not) | 0.36 | − 0.10 to 0.82 | 0.13 |
| Employment status (full-time work or not) | − 0.50 | − 0.95 to 0.05 | 0.03 |
Linear regression analysis was used to detect factors associated with MTX adherence
MTX methotrexate; RA rheumatoid arthritis; DAS28-ESR Disease Activity Score (28 joint count)-erythrocyte sedimentation rate; BMQ Beliefs about Medicines Questionnaire; CES-D Center for Epidemiological Studies Depression; SDS Social Desirability Scale; Coef regression coefficients; CI confidence interval